Resistant Starch - Glycemic (blood Sugar) Management

Glycemic (blood Sugar) Management

Consumption of natural resistant starch by humans has been shown to result in

• Decreased glycemic response in healthy individuals, decreased glycemic response in diabetics,

• Increase insulin sensitivity in healthy individuals, individuals with Type II diabetes as well as insulin resistant individuals. One study found a 50% increase in insulin sensitivity in overweight men consuming 15 grams of resistant starch/day for 4 weeks. One additional study found that 12 grams of ingredients containing resistant starch did not improve insulin sensitivity in African American adults at risk for diabetes.

• Increase glycemic health of next generation when fed to pregnant mothers An animal study demonstrated that when RS2 resistant starch from high amylose corn was fed to pregnant, diabetic rats, it resulted in increased insulin sensitivity and preservation of beta-cell mass within the pancreas of the dams as well as lower fasting blood glucose levels in the pups.

• Improves first phase insulin secretion A human clinical trial demonstrated improved first phase insulin secretion when RS2 resistant starch from high amylose corn was fed to overweight, insulin resistant adults.

Animal studies have shown that RS2 resistant starch from high amylose corn prevented the development of insulin resistance (compared to high glycemic starch), but does not reverse insulin resistance that has already developed.